Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
1977 3
1978 1
1979 1
1980 2
1981 2
1982 2
1983 1
1986 2
1988 2
1989 1
1990 5
1991 4
1992 1
1993 4
1994 5
1995 3
1996 4
1997 3
1998 6
1999 8
2000 3
2001 3
2002 6
2003 6
2004 5
2005 2
2006 6
2007 3
2009 2
2010 1
2011 1
2012 1
2013 1
2015 1
2016 3
2017 2
2018 2
2019 6
2020 1
2021 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.
Charlier C, Perrodeau É, Leclercq A, Cazenave B, Pilmis B, Henry B, Lopes A, Maury MM, Moura A, Goffinet F, Dieye HB, Thouvenot P, Ungeheuer MN, Tourdjman M, Goulet V, de Valk H, Lortholary O, Ravaud P, Lecuit M; MONALISA study group. Charlier C, et al. Lancet Infect Dis. 2017 May;17(5):510-519. doi: 10.1016/S1473-3099(16)30521-7. Epub 2017 Jan 28. Lancet Infect Dis. 2017. PMID: 28139432 Free article.
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.
Guigay J, Aupérin A, Fayette J, Saada-Bouzid E, Lafond C, Taberna M, Geoffrois L, Martin L, Capitain O, Cupissol D, Castanie H, Vansteene D, Schafhausen P, Johnson A, Even C, Sire C, Duplomb S, Evrard C, Delord JP, Laguerre B, Zanetta S, Chevassus-Clément C, Fraslin A, Louat F, Sinigaglia L, Keilholz U, Bourhis J, Mesia R; GORTEC; AIO; TTCC, and UniCancer Head and Neck groups. Guigay J, et al. Lancet Oncol. 2021 Apr;22(4):463-475. doi: 10.1016/S1470-2045(20)30755-5. Epub 2021 Mar 5. Lancet Oncol. 2021. PMID: 33684370 Clinical Trial.
Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial.
Taïeb J, Bouche O, André T, Le Malicot K, Laurent-Puig P, Bez J, Toullec C, Borg C, Randrian V, Evesque L, Corbinais S, Perrier H, Buecher B, Di Fiore F, Gallois C, Emile JF, Lepage C, Elhajbi F, Tougeron D; SAMCO-PRODIGE 54 Investigators. Taïeb J, et al. JAMA Oncol. 2023 Oct 1;9(10):1356-1363. doi: 10.1001/jamaoncol.2023.2761. JAMA Oncol. 2023. PMID: 37535388 Free PMC article.
[Anopheline population genetics].
Manguin S, Fontenille D, Chandre F, Lochouarn L, Mouchet J, Kengne P, Guillet P. Manguin S, et al. Among authors: guillet p. Bull Soc Pathol Exot. 1999 Sep-Oct;92(4):229-35. Bull Soc Pathol Exot. 1999. PMID: 10572657 Review. French.
Biotinylated non-ionic amphipols for GPCR ligands screening.
Bosco M, Damian M, Chauhan V, Roche M, Guillet P, Fehrentz JA, Bonneté F, Polidori A, Banères JL, Durand G. Bosco M, et al. Among authors: guillet p. Methods. 2020 Aug 1;180:69-78. doi: 10.1016/j.ymeth.2020.06.001. Epub 2020 Jun 4. Methods. 2020. PMID: 32505829
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial.
Guigay J, Ortholan C, Vansteene D, Cupissol D, Even C, Kaminsky MC, Sire C, Blot E, Debourdeau P, Bozec L, Saada-Bouzid E, Fayette J, Dalloz P, Pointreau Y, Caer HL, Falandry C, Digue L, Braccini A, Lopez S, Guillet P, Michel C, Cheurfa N, Schwob D, Bourhis J, Mertens C, Aupérin A; ELAN Group including Gustave Roussy, Unicancer GERICO and H&N groups and the GORTEC. Guigay J, et al. Among authors: guillet p. Lancet Healthy Longev. 2024 Mar;5(3):e182-e193. doi: 10.1016/S2666-7568(23)00284-2. Lancet Healthy Longev. 2024. PMID: 38432247 Free article. Clinical Trial.
Fluorinated diglucose detergents for membrane-protein extraction.
Boussambe GNM, Guillet P, Mahler F, Marconnet A, Vargas C, Cornut D, Soulié M, Ebel C, Le Roy A, Jawhari A, Bonneté F, Keller S, Durand G. Boussambe GNM, et al. Among authors: guillet p. Methods. 2018 Sep 1;147:84-94. doi: 10.1016/j.ymeth.2018.05.025. Epub 2018 May 30. Methods. 2018. PMID: 29857192
The duck EB66® cell substrate reveals a novel retrotransposon.
Perugi F, Freslon-Evain C, Batard L, Guillet P, Schwamborn K. Perugi F, et al. Among authors: guillet p. Biologicals. 2019 Sep;61:22-31. doi: 10.1016/j.biologicals.2019.08.001. Epub 2019 Aug 30. Biologicals. 2019. PMID: 31474416
121 results